As of July 2026, 17 paid clinical trials are recruiting in Yankton, South Dakota. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Yankton offers studies at sites including Avera Cancer Institute at Yankton for conditions such as Breast Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in Yankton, SD at 3 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Avera Cancer Institute at Yankton | Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma | 11 |
| Avera Cancer Institute - Yankton | Breast Cancer, CNS Cancer, Cancer | 5 |
| AMG Oncology and Hematology Avera Cancer Institute - Yankton | Breast Cancer | 1 |
Recruiting trials in Yankton grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 17 recruiting clinical trials in Yankton, South Dakota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Yankton compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Yankton include Breast Cancer (3), Recurrent Head and Neck Squamous Cell Carcinoma (2), Recurrent Hypopharyngeal Squamous Cell Carcinoma (2), Recurrent Laryngeal Squamous Cell Carcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Yankton on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Yankton include Avera Cancer Institute at Yankton, Avera Cancer Institute - Yankton, AMG Oncology and Hematology Avera Cancer Institute - Yankton, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Yankton are Cancer & tumors (15). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.